Provasc

Quick links to important sections

Provasc

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Provasc

Provasc is a synthetic single-ingredient prescription drug characterized by the long-acting calcium channel blocker Amlodipine. It is chemically defined as a dihydropyridine derivative, positioning it within a high-level pharmacological class used for managing specific cardiovascular conditions. Provasc is the original trade name for this compound, though the active ingredient, Amlodipine, is widely available under various generic names.


Quick Facts

Property Description
Active Ingredient Amlodipine (Amlodipine Besylate)
Form Oral Tablet, Oral Suspension
Pharmacological Class Calcium Channel Blocker (CCB)
Common Use Reducing High Blood Pressure and Angina
Origin Synthetic

What Type of Medicine is Provasc and What is its Composition?

Provasc's active ingredient is Amlodipine, which belongs to the class of Calcium Channel Blockers (CCBs). Its Dihydropyridine classification identifies it as an agent that blocks the entry of calcium ions into cells. This mechanism means the medicine primarily acts by relaxing blood vessels to improve flow, an effect clinically recognized for decades in the management of Hypertension.

This classification dictates that Amlodipine is a long-acting compound formulated for oral route of administration as a monotherapy. Its synthetic origin ensures a consistent and predictable therapeutic action and stability, which are key factors in its global use.


Provasc: Its General Purpose and Pharmaceutical Form

The general purpose of Provasc is to function as an Antihypertensive and Antianginal Agent, used, for example, to help stabilize blood pressure in hypertensive patients. Amlodipine is indicated for the treatment of both hypertension and chronic stable Angina Pectoris. This indicates the drug is effective in managing both high blood pressure and circulation-related chest discomfort.

The drug is commonly available as an Oral Tablet, where the Amlodipine is contained within a solid matrix. For broader patient accessibility, Amlodipine is also supplied in alternative dosage forms such as an Oral Suspension or Oral Solution, using an aqueous vehicle to allow for liquid ingestion via the oral route, a feature particularly relevant for pediatric patients or those with difficulty swallowing.

Regulatory References

  1. Amlodipine: MedlinePlus Drug Information
  2. Mechanism of Action: Amlodipine as a Calcium Channel Blocker
  3. NIH Drug Information Portal
  4. EMA Product Information

What side effects are possible with Provasc?

Possible Side Effects and Safety Information

The safety profile of Provasc (Amlodipine) is formally categorized by regulatory authorities based on frequency and affected physiological system. The adverse reactions are classified to provide an official description of the medicine's risk profile.


Official Adverse Reaction Classification

Adverse reactions are generally grouped into frequency tiers ranging from Common (may affect up to 1 in 10 people) to Very Rare (may affect fewer than 1 in 10,000 people). Common effects predominantly involve the Vascular and Nervous Systems.

Frequency Tier Examples of Officially Listed Effects
Common Edema (swelling of ankles), headache, fatigue, nausea, dizziness, palpitations, and flushing.
Uncommon Insomnia, somnolence, mood changes, tremor, rash, pruritus, arthralgia, and vomiting.

Serious Adverse Reactions and Safety Constraints

Regulatory documents specify certain clinically significant adverse events, even if they occur with Very Rare frequency. These include serious effects affecting the Hepatobiliary system, such as hepatitis and jaundice, as well as events affecting the Cardiac system, like myocardial infarction and arrhythmia.

Official safety notes document that an increase in the frequency or severity of angina or acute myocardial infarction has been observed at the initiation of therapy or during a dose increase, particularly in patients with severe obstructive coronary artery disease. Furthermore, specific cautions are noted for special populations: lower doses or slower titration are recommended for patients with impaired hepatic function due to reduced clearance.

Overdose and Emergency Response

A gross overdose of Provasc (Amlodipine) requires immediate emergency medical attention. Contacting emergency services is necessary upon a suspected overdose, even if symptoms are not yet apparent. Regulatory documents confirm that the principal manifestation of overdose is marked and probably prolonged systemic hypotension due to excessive peripheral vasodilation. This severe drop in blood pressure may lead to reflex tachycardia and carries the documented risk of progressing to life-threatening shock.

The long terminal elimination half-life of Amlodipine mandates an extended period of clinical monitoring in a hospital setting. No specific antidote is known for Amlodipine overdose, meaning management relies entirely on active cardiovascular support. Official guidance describes measures such as placing the patient in a supine position with elevation of extremities, monitoring fluid volume, and using a vasoconstrictor if hypotension remains refractory. Supportive procedures may include considering gastric lavage or the administration of activated charcoal to limit absorption. Frequent monitoring of cardiac and respiratory function remains an essential part of the required supportive treatment.

Therapeutic Uses of Provasc

Main Uses of Provasc

Provasc is a medication primarily prescribed for the management of cardiovascular conditions. It belongs to a class of drugs known as calcium channel blockers, which work by affecting the movement of calcium into the cells of the heart and blood vessels.

Hypertension (High Blood Pressure)

The primary use of Provasc is the treatment of hypertension. By relaxing the muscle cells in the walls of the arteries, the medication allows blood vessels to widen. This physiological change reduces the resistance to blood flow, resulting in lower blood pressure levels. Consistent management of blood pressure is a key factor in reducing the long-term risk of cardiovascular complications.

Coronary Artery Disease and Angina

Provasc is also indicated for the treatment of various forms of angina, which is chest pain caused by a reduced supply of oxygen to the heart muscle. It is used in the following contexts:

  • Chronic Stable Angina: It helps manage exertional chest pain by improving blood flow and reducing the workload on the heart.
  • Vasospastic Angina (Prinzmetal's Angina): It is effective in treating chest pain caused by sudden spasms of the coronary arteries.
  • Documented Coronary Artery Disease: In patients with confirmed narrowing of the arteries, the medication may be used to reduce the frequency of angina episodes and the need for hospitalization related to heart complications.

Benefits of Treatment

The clinical benefits of Provasc center on its ability to provide long-term stabilization of blood pressure and cardiac oxygen supply. Because the medication has a gradual onset of action, it helps prevent sudden drops in blood pressure.

Effective use of this medication contributes to:

  • Improved Exercise Tolerance: By reducing the frequency of angina attacks, patients may find it easier to engage in daily physical activities.
  • Vascular Protection: Maintaining blood pressure within a healthy range helps protect vital organs, such as the kidneys and brain, from damage caused by chronic hypertension.
  • Management of Ischemia: By preventing arterial spasms, the medication ensures a more consistent supply of oxygenated blood to the heart tissue.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Scope

The eligibility for Provasc (Amlodipine) is defined by regulatory limitations based on patient demographics and pre-existing conditions.

Classification Population Rule (Official Labeling)
Populations Allowed Adults (18+ years) are eligible for all approved uses. Children aged 6 to 17 are permitted only for the treatment of hypertension.
Contraindicated Use is strictly prohibited for patients with known hypersensitivity to Amlodipine or other dihydropyridine derivatives. The medicine must not be used in cases of severe hypotension, shock (including cardiogenic shock), and high-grade Aortic Stenosis (outflow obstruction).
Use Restricted/Not Recommended The medicine is generally not recommended for use in children under 6 years of age, as safety and efficacy are not established. It is also not recommended for individuals who are pregnant or breastfeeding.

Condition-Specific Eligibility Rules

For patients with organ function issues, use is conditional. Patients with renal impairment may typically use the medicine without required dosage adjustment. However, use in patients with hepatic impairment (liver dysfunction) requires caution due to reduced drug clearance, especially in cases of severe impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation confirms that the interaction profile of Provasc (Amlodipine) is defined by its metabolic pathway and the risk of additive effects. Official regulatory bodies have identified interactions that significantly alter drug exposure and those that pose a risk of enhanced pharmacodynamic effects.


Documented Pharmacokinetic Interactions

Interacting Substance Type Official Interaction Outcome
CYP3A4 Inhibitors (e.g., Ketoconazole) Causes a regulatory-documented increase in the systemic exposure of Amlodipine.
CYP3A4 Inducers (e.g., Rifampicin) May cause a decrease in the plasma concentration of Amlodipine, potentially reducing its clinical effect.
Immunosuppressants (e.g., Tacrolimus) Amlodipine co-administration increases the systemic exposure of the immunosuppressant.

Documented Pharmacodynamic Interactions and Restrictions

Co-administration with other blood pressure lowering agents, including PDE-5 inhibitors (e.g., Sildenafil), may result in an additive hypotensive effect. Amlodipine also increases the systemic exposure of Simvastatin, leading to the official restriction that the Simvastatin dose must be limited to 20 mg daily.

Separately, Grapefruit or Grapefruit Juice is officially not recommended due to its documented potential to increase Amlodipine's bioavailability. For patients with severe hepatic impairment, the official label notes that the prolonged elimination half-life increases systemic exposure and requires cautious administration.

Mechanism of Action

How Provasc Works

The mechanism of Amlodipine (Provasc) is centered on the selective regulation of calcium ion entry into specific muscle cells, defining its hemodynamic effect profile.


Molecular Target: Blockade of L-Type Calcium Channels

The drug's action begins at the cellular level by selectively and effectively blocking the L-type Voltage-Dependent Calcium Channel ( L-VDCC), which is highly concentrated in the cell membranes of arterial smooth muscle. This inhibition prevents the influx of extracellular calcium ions ( Ca^2+), the essential signal required for muscle cell contraction. This mechanism, due to the drug's slow dissociation from the target, is responsible for the drug's long duration of blockade by maintaining suppression of the primary trigger for vascular tension.


Mechanistic Cascade: Reduction of Systemic Vascular Tone

By blocking Ca^2+ entry, the drug halts the excitation-contraction coupling pathway in the vascular smooth muscle, causing the vessel walls to relax and widen (vasodilation). This reduction in the muscular tension of the small arteries leads to a decrease in Total Peripheral Resistance ( TPR) throughout the systemic circulation. This physiological change represents the causal bridge between the molecular block and the resulting change in systemic vascular dynamics.


Physiological Result: Afterload Reduction and Myocardial Energy Modulation

The vasodilation resulting from the lowered TPR directly reduces the afterload—the mechanical resistance the heart's left ventricle must overcome to pump blood. This decrease in resistance reduces the energy expenditure of the heart and simultaneously reduces its myocardial oxygen demand. The mechanism is highly arterial-selective, meaning its physiological effect is concentrated on regulating systemic pressure dynamics rather than affecting venous capacity or directly suppressing cardiac contractility.

Dosage and Administration Information

The administration of Provasc (Amlodipine) is defined by established parameters that mandate a precise, long-term oral regimen.

Administration Scope

The route of administration is oral, available in both solid (tablet) and liquid (solution/suspension) forms. The standard adult dosing schedule begins with an initial dose of 5 mg taken once daily. This dose may be adjusted upward to a maximum of 10 mg once daily to maintain effectiveness. Dose adjustments, or titration, should occur only after a period of 7 to 14 days to allow the medicine to reach its full therapeutic effect.

Amlodipine can be taken with or without food, but it is generally instructed to be taken at the same time each day to ensure consistent drug levels. For specific populations, protocols specify a lower starting dose of 2.5 mg once daily, particularly for older adults or patients with hepatic impairment. For pediatric patients (aged 6 to 17) being treated for hypertension, the maximum dose is 5 mg once daily.

If a dose is missed, it is generally recommended to take it as soon as possible, unless it is close to the time for the next scheduled dose, in which case the missed dose should be skipped.

Instruction Classifications

The frequency pattern is once daily, reflecting the compound's long-acting profile. The basis for this schedule emphasizes the need for consistent plasma concentration, making daily intake a requirement for its intended long-term use.

Recent Clinical Evidence

Provasc: Recent Clinical Evidence

Provasc (amlodipine besylate) is a long-acting calcium channel blocker used for the management of hypertension (high blood pressure) and angina (chest pain).

Clinical research spanning over three decades has established the effectiveness and profile of amlodipine. Landmark studies and meta-analyses have focused on its role as both a primary and additive therapy for cardiovascular conditions.


Evidence in Hypertension Management

Studies have consistently demonstrated that amlodipine, administered once daily, is associated with statistically significant reductions in both systolic and diastolic blood pressure. The sustained 24-hour effect of the medication is a key finding noted across trials. Recent analyses reaffirm its standing as a valuable first-line option for hypertension in a broad patient population, often used alone or in combination with other anti-hypertensive agents.

Evidence in Angina and Coronary Artery Disease

In patients with chronic stable angina or vasospastic angina (Prinzmetal's angina), clinical trials indicate that amlodipine administration may reduce the frequency of anginal attacks and increase the total exercise time before the onset of symptoms. Additionally, for patients with angiographically documented coronary artery disease (CAD) who do not have heart failure, evidence suggests its use may be associated with a reduced risk of hospitalization for angina and a lower risk of requiring coronary revascularization procedures.


Safety and Tolerability Profile

Long-term data from observational and randomized controlled trials show that amlodipine is generally considered safe and well-tolerated. A recent review analyzing clinical trial data and real-world evidence addressed past concerns by concluding that amlodipine use was not associated with an increased risk of heart failure in hypertensive patients. The most commonly reported side effects across studies include peripheral edema (swelling of the ankles or feet), headache, and dizziness.

Frequently Asked Questions (FAQ)

Common questions about Provasc (FAQ)


Q: Is it normal to feel tired when starting Provasc?

A: Tiredness, often described as fatigue, is listed in official safety documentation as a common side effect. Clinical experience suggests that some side effects may potentially lessen as the body adjusts to the medicine, but this is not guaranteed for every individual.


Q: Is the low blood pressure feeling after taking Provasc a common side effect?

A: The feeling of lightheadedness or dizziness is noted in safety documentation as a common side effect. The drug's purpose is to manage blood pressure, and official warnings note that actual low blood pressure (hypotension) is a possible effect, particularly in certain patient groups.


Q: Can I take Provasc if I have kidney problems?

A: Official labeling states that for patients with general kidney (renal) impairment, no routine dosage adjustment is typically required. Official documentation indicates that the drug's metabolism and clearance do not typically require dosage alteration in these cases.


Q: Can I stop taking Provasc if my blood pressure improves?

A: Official documentation classifies this medication as a long-term oral regimen intended to maintain consistent effectiveness over time. The medication is defined as a long-term regimen to maintain a consistent therapeutic effect, rather than an on-demand treatment for temporary blood pressure improvements.


Q: How long can a person stay on Provasc?

A: Official documents describe this medication as being intended for long-term treatment as a chronic, once-daily oral regimen. This is necessary to consistently maintain the therapeutic effect on blood pressure and related conditions.


Q: What is the typical timeframe for seeing the full effect of Provasc?

A: Official regulatory documentation states that the medication reaches steady-state plasma levels—meaning a consistent amount in the bloodstream—after approximately 7 to 8 days of consecutive daily dosing. This timeframe is often used as the window for deciding whether a dosage adjustment is appropriate.


Q: Can Provasc interact with herbal supplements?

A: Information derived from official sources suggests that individuals should discuss all other medications and herbal products they use with their healthcare provider. This is because possible interactions or unintended effects may exist.


Q: Is it safe to drink alcohol while taking Provasc?

A: Official patient information notes that the medication may have additive effects with alcohol in lowering blood pressure. Due to potential additive blood pressure lowering effects, there may be an increased risk of side effects such as dizziness or lightheadedness.


Q: Does Provasc have an effect on cholesterol levels?

A: Clinical data indicates that this class of medication is generally considered metabolically neutral. This means it is not typically associated with adverse changes to the serum lipid profile, such as cholesterol or triglyceride levels.


Q: Are there any documented long-term risks associated with Provasc?

A: Long-term clinical data is described in official documents, and the medication is generally considered safe and well-tolerated. Any associated risk is detailed within the officially listed adverse reactions, which cover events ranging from common to very rare.


Q: Is Provasc an effective treatment for all types of chest pain?

A: Official indications state the drug is approved for the treatment of chronic stable angina pectoris and vasospastic angina (a type of chest pain caused by artery spasms). It is not indicated for all types of chest pain.


Q: How quickly does Provasc start to work after the first dose?

A: Official pharmacokinetic information states that following an oral dose, the medication reaches peak plasma concentrations—the highest amount in the bloodstream—between 6 and 12 hours. The overall blood pressure lowering effect is designed to be maintained for at least 24 hours.


Q: Does Provasc interact with common over-the-counter pain relievers?

A: Official sources advise caution when taking this medication with certain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen. These pain relievers may potentially affect the medication’s blood pressure-lowering effect.


Q: Is Provasc safe for people with diabetes?

A: Official documents do not list diabetes mellitus as a contraindication for use. Clinical data suggests that this medication is generally considered metabolically neutral, meaning it does not typically cause negative interference with blood sugar control.


Q: Can people with asthma take Provasc?

A: Official documentation does not list asthma or other common respiratory conditions as a contraindication for use. The drug's mechanism of action is focused on the vascular system, and respiratory conditions are not listed among the contraindications.


Q: What happens if a child accidentally takes Provasc?

A: Official overdose information notes that taking too much of the medication can lead to excessive widening of blood vessels (vasodilation). These events may result in significant hypotension (low blood pressure) due to excessive widening of blood vessels.


Q: Does Provasc cause weight gain?

A: Weight changes are not listed among the commonly reported side effects in the official safety documentation for this medication. Side effect profiles typically focus on those effects most often reported in clinical trials.


Q: Does Provasc have a risk of causing a cough, like some other blood pressure medicines?

A: Cough is listed in the official safety profile as a reported side effect, though it is not categorized among the most common adverse events.


Q: Can Provasc affect my mood?

A: Official safety documentation reports mood changes as an uncommon side effect of the medication. This may include feelings such as anxiety or nervousness.


Q: Is it mandatory to have blood tests while taking Provasc?

A: Routine or mandatory blood tests are not specified for the general patient population in the official labeling. However, monitoring may be recommended for certain groups, particularly those with existing liver impairment.


Q: Can Provasc make my heart race?

A: The sensation of a fast or irregular heartbeat (palpitations) is listed in the official safety documents as a common side effect.


Q: Is Provasc related to Viagra or Cialis?

A: This medication belongs to the drug class of Calcium Channel Blockers and is not chemically related to the agents known as Viagra or Cialis, which are PDE-5 inhibitors. However, a documented interaction exists for additive blood pressure lowering effects when these drugs are co-administered.


Q: Does taking Provasc make it difficult to drive?

A: Official patient information advises caution with activities such as driving or operating hazardous machinery until you know how the medication affects you. This warning is in place due to the possibility of common side effects like dizziness or tiredness.


Q: Are there gender-specific differences in how Provasc works?

A: Clinical studies have examined differences in how the body processes the medication. Official information indicates that women may experience slightly higher plasma concentrations and potentially greater blood pressure reduction compared to men.


Q: How does Provasc compare to diuretics for blood pressure?

A: This medication is classified as a Calcium Channel Blocker, which acts by causing the blood vessels to relax. Diuretics are a separate class of drugs that work by increasing the amount of fluid and salt released in urine.


Q: Can Provasc affect fertility in men or women?

A: There is no evidence in official documents to suggest that this medication reduces fertility in women. However, non-clinical studies have suggested that the medication may affect male fertility by potentially impacting sperm function.

How should Provasc be stored and disposed of?

The storage of Provasc (amlodipine besylate) tablets must adhere strictly to regulated conditions to maintain product stability.

Storage Conditions and Requirements

  • Temperature: Store at Controlled Room Temperature, specifically between 20 to 25 C (68 to 77 F), with excursions permitted up to 30 C (86 F).
  • Protection: The tablets must be protected from light, excess heat, and moisture, and should not be stored in high-humidity areas like a bathroom.
  • Container: Keep the medication in its original, tightly closed, light-resistant container.
  • Child Safety: The container must be kept out of the sight and reach of children and pets to prevent accidental ingestion.

Disposal Instructions

Unused or expired Provasc should be disposed of through a medication take-back program when available. If a program is not accessible, the tablets must be mixed with an undesirable substance (like dirt or used coffee grounds) and sealed in a bag before being placed in household trash, following official guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Provasc found in:

A-Z Index: